2023 AMERICAN ACADEMY OF DERMATOLOGY (AAD) ANNUAL MEETING


Associated tags: Abstract, Quality of life, Risankizumab, EASI, Sleep, Safety, Hidradenitis suppurativa, Patient, Dermatology, American Academy, AbbVie, NORTH, Head, Itch, Atopic dermatitis, ABBV, NYSE, Psoriasis, Research, AAD

AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting

Retrieved on: 
Monday, March 13, 2023
Abstract, NORTH, AAD, Research, Psoriasis, NYSE, ABBV, Atopic dermatitis, Itch, Head, AbbVie, Quality of life, American Academy, Dermatology, Patient, Hidradenitis suppurativa, Safety, Sleep, EASI, Risankizumab, Pharmaceutical industry

NORTH CHICAGO, Ill., March 13, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one late-breaking presentation during the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21, in New Orleans, Louisiana.  

Key Points: 
  • "The data at this year's AAD conference demonstrate AbbVie's commitment to investing in its dermatology portfolio to further improve outcomes for patients with immune-mediated skin conditions," said Celine Goldberger, M.D., vice president, head of U.S. medical affairs, AbbVie.
  • The oral and poster presentations from AbbVie highlight research across the company's collective portfolio, further demonstrating leadership in dermatology innovation.
  • Data feature outcomes in psoriatic disease, atopic dermatitis and hidradenitis suppurativa to support patients living with immune-mediated skin conditions.
  • The 2023 AAD Annual Meeting e-Posters are available here and late-breaking sessions are available here .